Your browser doesn't support javascript.
loading
Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial.
Xu, Rui-Hua; Shen, Lin; Wang, Ke-Ming; Wu, Gang; Shi, Chun-Mei; Ding, Ke-Feng; Lin, Li-Zhu; Wang, Jin-Wan; Xiong, Jian-Ping; Wu, Chang-Ping; Li, Jin; Liu, Yun-Peng; Wang, Dong; Ba, Yi; Feng, Jue-Ping; Bai, Yu-Xian; Bi, Jing-Wang; Ma, Li-Wen; Lei, Jian; Yang, Qing; Yu, Hao.
Afiliación
  • Xu RH; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, Guangdong, P. R. China.
  • Shen L; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, No 52, Fucheng Road, Haidian District, Beijing, 100142, P. R. China. lin100@medmail.com.cn.
  • Wang KM; Department of Medical Oncology, Second Affiliated Hospital of Nanjing Medical University, Nanjing, 210011, Jiangsu, P. R. China.
  • Wu G; Cancer Center of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei, P. R. China.
  • Shi CM; Department of Medical Oncology, Fujian Medical University Union Hospital, Fuzhou, 350001, Fujian, P. R. China.
  • Ding KF; Department of Surgical Oncology, Second Hospital Affiliated to Zhejiang University School of Medicine, Hangzhou, 310009, Zhejiang, P. R. China.
  • Lin LZ; Department of Oncology, First Affiliated Hospital of Guangzhou Medical University of Chinese Medicine, Guangzhou, 510405, Guangdong, P. R. China.
  • Wang JW; Department of Medical Oncology, Chinese Academy of Medical Sciences Cancer Hospital, Beijing, 100021, P. R. China.
  • Xiong JP; Department of Medical Oncology, First Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, P. R. China.
  • Wu CP; Department of Medical Oncology, First People's Hospital of Changzhou, Changzhou, 213003, Jiangsu, P. R. China.
  • Li J; Department of Medical Oncology, Fudan University Cancer Hospital, Shanghai, 200032, P. R. China.
  • Liu YP; Department of Medical Oncology, First Hospital of China Medical University, Shenyang, 110001, Liaoning, P. R. China.
  • Wang D; Cancer Center, Daping Hospital and Institute of Surgery Research, Third Military Medical University, Chongqing, 400042, P. R. China.
  • Ba Y; Department of Gastrointestinal Medical Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, P. R. China.
  • Feng JP; Department of Oncology, PuAi Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430032, Hubei, P. R. China.
  • Bai YX; Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, 150081, Heilongjiang, P. R. China.
  • Bi JW; Department of Oncology, Jinan Military General Hospital, Jinan, 250000, Shandong, P. R. China.
  • Ma LW; Department of Tumor Chemotherapy and Radiology, Peking University Third Hospital, Beijing, 100191, P. R. China.
  • Lei J; Department of Gastrointestinal Surgery, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, Guangdong, P. R. China.
  • Yang Q; Department of Clinical Medicine, Jiangsu Hengrui Medicine Co., Ltd, Lianyungang, 222047, Jiangsu, P. R. China.
  • Yu H; Department of Epidemic and Health Statistics, Nanjing Medical University, Nanjing, 211166, Jiangsu, P. R. China.
Chin J Cancer ; 36(1): 97, 2017 12 22.
Article en En | MEDLINE | ID: mdl-29273089

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirroles / Neoplasias Colorrectales / Inhibidores de Proteínas Quinasas / Indoles Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male Idioma: En Revista: Chin J Cancer Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirroles / Neoplasias Colorrectales / Inhibidores de Proteínas Quinasas / Indoles Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male Idioma: En Revista: Chin J Cancer Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article